CIENCIASMEDICASNEWS: Statement—Large Clinical Trial Will Test Combination Monoclonal Antibody Therapy for Mild/Moderate COVID-19 | NIH: National Institute of Allergy and Infectious Diseases

miércoles, 6 de enero de 2021

Statement—Large Clinical Trial Will Test Combination Monoclonal Antibody Therapy for Mild/Moderate COVID-19 | NIH: National Institute of Allergy and Infectious Diseases

Statement—Large Clinical Trial Will Test Combination Monoclonal Antibody Therapy for Mild/Moderate COVID-19 | NIH: National Institute of Allergy and Infectious Diseases

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)